Advances In Pediatric Transplant: T-Cell Depleted Haploidentical Experience

T cell–depleted haploidentical HSCT is reshaping donor accessibility for pediatric patients who lack matched donors, offering a promising path forward with reduced GVHD risk. This webinar highlights one center’s experience using αβ T cell and CD19 B-cell-depleted grafts in children with both malignant and non-malignant conditions. Gain insights into the practical realities of implementing this approach, including clinical outcomes, immune reconstitution, and post-transplant complications.

Whether you're evaluating transplant strategies or seeking to optimize patient outcomes, this discussion offers a valuable clinical perspective.